[PHARMA] YoY Annualized Quarter Result on 31-Mar-2017 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
16-May-2017
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2017
Quarter
31-Mar-2017 [#1]
Profit Trend
QoQ- 65.99%
YoY- 2.96%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 3,279,684 3,144,432 2,471,692 2,473,176 2,236,780 1,887,616 1,874,688 9.76%
PBT 123,520 120,972 114,828 111,108 106,152 154,448 152,636 -3.46%
Tax -33,860 -42,380 -44,472 -34,076 -32,272 -26,744 -46,052 -4.99%
NP 89,660 78,592 70,356 77,032 73,880 127,704 106,584 -2.83%
-
NP to SH 89,596 78,468 70,344 75,692 73,516 127,176 104,868 -2.58%
-
Tax Rate 27.41% 35.03% 38.73% 30.67% 30.40% 17.32% 30.17% -
Total Cost 3,190,024 3,065,840 2,401,336 2,396,144 2,162,900 1,759,912 1,768,104 10.32%
-
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.22%
Dividend
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Div 62,695 62,521 51,964 41,475 41,417 72,494 41,408 7.15%
Div Payout % 69.98% 79.68% 73.87% 54.79% 56.34% 57.00% 39.49% -
Equity
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Net Worth 350,047 528,825 524,838 544,360 515,906 528,173 515,022 -6.22%
NOSH 261,229 260,505 259,821 259,219 258,859 258,908 258,805 0.15%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin 2.73% 2.50% 2.85% 3.11% 3.30% 6.77% 5.69% -
ROE 25.60% 14.84% 13.40% 13.90% 14.25% 24.08% 20.36% -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 1,255.48 1,207.05 951.31 954.09 864.09 729.07 724.36 9.59%
EPS 34.28 30.12 27.08 29.20 28.40 49.12 40.52 -2.74%
DPS 24.00 24.00 20.00 16.00 16.00 28.00 16.00 6.98%
NAPS 1.34 2.03 2.02 2.10 1.993 2.04 1.99 -6.37%
Adjusted Per Share Value based on latest NOSH - 259,219
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
RPS 227.56 218.18 171.50 171.60 155.20 130.97 130.08 9.75%
EPS 6.22 5.44 4.88 5.25 5.10 8.82 7.28 -2.58%
DPS 4.35 4.34 3.61 2.88 2.87 5.03 2.87 7.17%
NAPS 0.2429 0.3669 0.3642 0.3777 0.358 0.3665 0.3573 -6.22%
Price Multiplier on Financial Quarter End Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 -
Price 1.26 2.27 4.28 4.89 5.76 6.00 4.46 -
P/RPS 0.10 0.19 0.45 0.51 0.67 0.82 0.62 -26.20%
P/EPS 3.67 7.54 15.81 16.75 20.28 12.21 11.01 -16.71%
EY 27.22 13.27 6.33 5.97 4.93 8.19 9.09 20.03%
DY 19.05 10.57 4.67 3.27 2.78 4.67 3.59 32.03%
P/NAPS 0.94 1.12 2.12 2.33 2.89 2.94 2.24 -13.46%
Price Multiplier on Announcement Date
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Date 19/05/20 16/05/19 16/05/18 16/05/17 13/05/16 18/05/15 14/05/14 -
Price 1.88 2.36 4.07 4.72 5.60 6.91 4.70 -
P/RPS 0.15 0.20 0.43 0.49 0.65 0.95 0.65 -21.66%
P/EPS 5.48 7.83 15.03 16.16 19.72 14.07 11.60 -11.73%
EY 18.24 12.76 6.65 6.19 5.07 7.11 8.62 13.29%
DY 12.77 10.17 4.91 3.39 2.86 4.05 3.40 24.65%
P/NAPS 1.40 1.16 2.01 2.25 2.81 3.39 2.36 -8.32%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment